Tag: Vaccines
COVID-19 Vaccination Cover Varies With Social Vulnerability
Coverage higher in low versus high social vulnerability counties for overall measure of social vulnerability index
U.S. to ‘Loan’ COVID-19 Vaccines to Mexico, Canada
Ensuring Canada and Mexico can contain the pandemic will aid in the effort to reopen borders
Flu Vaccine Rate Expected to Reach All-Time High for 2020-2021 Season
Two-thirds saying they have or will get vaccine was driven by interest from adults 60 years and older
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Guidance relates to risks for allergic reactions for mRNA (Moderna and Pfizer) and adenovirus vector (Johnson & Johnson) COVID-19 vaccines
ChAdOx1 nCoV-19 Vaccine Does Not Protect Against B.1.351 SARS-CoV-2 Variant
Vaccine efficacy was 10.4 percent against the B.1.351 variant of SARS-CoV-2, first described in South Africa
AstraZeneca Vaccine Safe and Effective, European Medicines Agency Says
Officials hope announcement will ease concerns about possible rare side effects involving blood clots
Florida Baby First in U.S. Born With COVID-19 Antibodies
Mother received her first shot of the Moderna COVID-19 vaccine when she was 36 weeks pregnant
Most People Complete Two-Dose COVID-19 Vaccination Series
Of those receiving a second COVID-19 vaccine dose, 95.6 percent did so within the recommended interval
States Broaden COVID-19 Vaccine Access to Millions of Americans
At the beginning of the rollout, vaccines were available only to the most vulnerable Americans and some essential workers
Partial Pfizer COVID-19 Vaccination 63 Percent Effective
Estimated effectiveness 63 percent for period from more than 14 days after the first dose through seven days after the second dose












